Vanguard Group Inc Rhythm Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,444,926 shares of RYTM stock, worth $211 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,444,926

Previous 3,442,600 0.07%

Holding current value

$211 Million

Previous $192 Million 5.18%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$48.56 - $61.02 $112,950 - $141,932	2,326 Added 0.07%	3,444,926 $182 Million
Q4 2024 Feb 11, 2025	SELL	$46.91 - $67.33 $249,139 - $357,589	-5,311 Reduced 0.15%	3,442,600 $192 Million
Q3 2024 Nov 13, 2024	BUY	$40.81 - $55.0 $3.56 Million - $4.8 Million	87,216 Added 2.6%	3,447,911 $181 Million
Q2 2024 Aug 13, 2024	BUY	$35.41 - $44.37 $2 Million - $2.51 Million	56,549 Added 1.71%	3,360,695 $138 Million
Q1 2024 May 10, 2024	BUY	$39.12 - $52.44 $3.02 Million - $4.05 Million	77,208 Added 2.39%	3,304,146 $143 Million
Q4 2023 Feb 14, 2024	BUY	$21.39 - $49.64 $4.54 Million - $10.5 Million	212,370 Added 7.04%	3,226,938 $148 Million
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $1.35 Million - $2.37 Million	85,139 Added 2.91%	3,014,568 $69.1 Million
Q2 2023 Aug 14, 2023	BUY	$16.32 - $21.15 $4.59 Million - $5.95 Million	281,293 Added 10.62%	2,929,429 $48.3 Million
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $874,755 - $1.77 Million	51,822 Added 2.0%	2,648,136 $47.2 Million
Q4 2022 Feb 10, 2023	BUY	$22.21 - $30.25 $8.04 Million - $11 Million	362,042 Added 16.2%	2,596,314 $75.6 Million
Q3 2022 Nov 14, 2022	BUY	$4.3 - $30.85 $363,547 - $2.61 Million	84,546 Added 3.93%	2,234,272 $54.7 Million
Q2 2022 Aug 12, 2022	SELL	$3.12 - $12.25 $334,757 - $1.31 Million	-107,294 Reduced 4.75%	2,149,726 $8.92 Million
Q1 2022 May 13, 2022	SELL	$6.13 - $12.24 $407,651 - $813,972	-66,501 Reduced 2.86%	2,257,020 $26 Million
Q4 2021 Feb 14, 2022	BUY	$8.62 - $13.9 $90,018 - $145,157	10,443 Added 0.45%	2,323,521 $23.2 Million
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $650,062 - $1.15 Million	55,656 Added 2.47%	2,313,078 $30.2 Million
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $41.8 Million - $50.9 Million	2,257,422 New	2,257,422 $44.2 Million

Others Institutions Holding RYTM

# of Institutions

245

Shares Held

62.9M

Call Options Held

403K

Put Options Held

62.8K

View Full List

About RHYTHM PHARMACEUTICALS, INC.

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.42B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

More about RYTM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Rhythm Pharmaceuticals, Inc. Transaction History